Introduction
A congenital hemoglobin disease called β-thalassemia major needs frequent blood transfusions. Among other consequences, diabetes mellitus and iron overload are frequently linked to the condition. Insulin resistance is brought on by pancreatic iron overload in β-thalassemia patients, impairs β-cell activity and insulin secretion. Patients with β-thalassemia are more likely to develop diabetes due to several risk factors, such as gender, advanced age, obesity, sedentary lifestyles, and family histories of the disease. Some thalassemia patients tend to acquire diabetes, which makes managing their condition even more difficult. Individuals with thalassemia must take all necessary precautions to avoid diabetes and adhere to their treatment regimen. The article below brings up-to-date information on glucose anomalies in patients with type 1 diabetes and emphasizes the need for prompt diagnosis and appropriate treatment.
What Is Thalassemia?
A genetic blood condition called thalassemia (thal-uh-SEE-me-uh) results in the body having less hemoglobin than usual. Red blood cells can carry oxygen because hemoglobin is present. Anemia from thalassemia can make one feel exhausted. In mild cases of thalassemia, therapy may not be necessary. However, more severe types may necessitate frequent blood transfusions. Individuals can manage their weariness by exercising frequently and maintaining a nutritious diet.
Thalassemia comes in various forms. The condition's kind and severity will determine the symptoms and signs they experience. Signs and symptoms of thalassemia may include:
-
Weakness and fatigue.
-
Deformities of the facial bones.
-
Pale or yellowish skin.
-
Gradual expansion.
-
Stomach edema.
-
Dark-colored urination.
Some infants with thalassemia exhibit symptoms and indicators from birth, whereas others experience them in their first two years of life. Some patients without signs of thalassemia have only one mutated hemoglobin gene.
Severe thalassemia can result in heart failure. Some cases can result in early death (between the ages of 20 and 30). The results are improved with regular blood transfusions and iron-removal therapy. The lifetime is frequently not shortened by less severe forms of thalassemia. Diabetes (DM) and glucose tolerance (IGT) emphasize early detection and appropriate treatment. Thalassemia significantly causes liver issues and cardiac failure if left untreated. Additionally, it increases the risk of infections.
What Is the Connection Between Thalassemia and Diabetes?
Diabetes is an endocrine disorder that affects a large portion of the general population. Individuals with a family history of diabetes, as well as those who are overweight, inactive, and have high blood pressure, are most at risk of acquiring diabetes. In addition to these additional variables, iron overload and the common co-occurrence of viral infections and liver illness in thalassemia patients are the main causes of diabetes.
Diabetes develops when the body's ability to process the sugar in food is compromised. Normally, when a person eats, the body converts food into glucose or sugar, which is then released into the bloodstream. The pancreas secretes the hormone insulin, which causes sugar to be transferred from the blood into the cells, where it is used as fuel. When a person has diabetes, their body either produces insufficient insulin or is unable to use it effectively, which results in an excess of sugar in the blood that cannot be used by the cells as fuel. Diabetes is a dangerous condition that can lead to blindness and damage to the eyes, neuropathy (numbness or tingling in the hands, feet, or legs), heart and blood vessel issues, non-healing wounds, kidney issues, and recurrent—urinary tract infections as well as issues about sex.
Diabetes comes in two flavors: Type 1 and Type 2, both of which have issues with insulin and blood sugar. The pancreas can no longer produce insulin in people with type 1. Because it usually affects young individuals, this condition was formerly known as juvenile diabetes. However, it can happen to anyone at any age when the pancreatic cells stop producing insulin. Some people may not have diabetes and frequently do not exhibit any symptoms, but they do have impaired glucose tolerance, which causes their blood sugar levels to be slightly higher than normal. Nonetheless, if thalassemia patients disregard their treatment regimens, they frequently go on to get diabetes.
Suggestions for Individuals Suffering From Major B-Thalassemia:
The last ten years have seen a significant rise in life expectancy for people with thalassemia major (TM), mostly due to better medical care, especially iron chelation therapy guided by magnetic resonance imaging technology. Other non-cardiac morbidities become more noticeable as life expectancy increases. This review updated the current understanding concerning glycemic abnormalities in TM patients (impaired glucose tolerance or IGT) and emphasized the importance of early identification and appropriate care. Abnormalities in glucose homeostasis are rather common sequelae.
-
Get a Diabetic Screening and Decide to Use Iron Chelation Therapy: Individuals with beta-thalassemia major should have routine diabetes screenings. The best way to delay the formation of diabetes and restore normal blood glucose levels in its early stages is to combine a balanced lifestyle with appropriate iron chelation therapy.
-
Verify Cardiac Risk and Blood Glucose Levels: Reducing the risk of cardiovascular disease, preventing complications, and maintaining appropriate blood glucose control are the main goals of diabetes management. Some oral antidiabetic medications can be used after diabetes develops, but insulin remains the cornerstone of treatment for the large number of thalassemia patients who are insulin deficient.
-
Handle Diabetes Well: One of the biggest obstacles a person with thalassemia may encounter is managing diabetes. Encouraging individuals to take charge of their diabetes and offering assistance from collaborative specialized teams are essential to successful diabetes management. Until then, people with diabetes and thalassemia will not be able to live long, healthy lives.
Conclusion
Uncontrolled iron overload in TM patients has major clinical ramifications, including significant morbidity and mortality. Heart problems, endocrine disorders, and liver damage are among the complications. One significant TM consequence is diabetes. Anomalies related to glucose homeostasis have intricate and multifaceted mechanisms. It is important to raise awareness of thalassemia and its associated problems. Patients must know they have a complex and uncommon blood condition requiring multiple specialists' care. Therefore, it is imperative that they receive an early diagnosis, become informed about their condition, and choose healthy preventive measures. It is crucial to speak with the most expert. A hematologist should be their primary care physician, with support from endocrinologists, cardiologists, and gastroenterologists throughout treatment. Self-medication is never advised and ought to be avoided at all costs.
